Skip to main content

HomeResearchOvagen

CategoryLongevity
SafetyLow Risk
StatusResearch Only

Ovagen

liver peptide bioregulator · hepatic Khavinson peptide · liver cytomax

CategoryLongevity
Half-life
Routeoral, subcutaneous
RiskLow Risk
Providers1 listed

About Ovagen

Liver-targeted peptide complex modulating hepatocyte gene expression. Supports liver cell regeneration, enzyme function normalization, and hepatic protein synthesis.

A short peptide bioregulator derived from liver tissue, developed by the Khavinson Institute. Studied for restoration of hepatic function, detoxification pathway support, and anti-aging effects on liver tissue.

Research Areas

liver supportdetoxificationhepatic regenerationlongevity

Regulatory & Evidence

Risk Profile

Low Risk

Generally considered lower risk in research contexts. Risk profile varies by individual — review contraindications before use.

Regulatory Status

Availability Status
Research Only

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Safety Notes

Low Risk

Generally considered lower risk in research contexts. Individual response varies — review all considerations before use.

Reported contraindications & considerations

Kidney Or Liver ConditionPregnant Or Nursing

Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.

Where to Find Ovagen

1 provider

Frequently Asked Questions — Ovagen

A short peptide bioregulator derived from liver tissue, developed by the Khavinson Institute. Studied for restoration of hepatic function, detoxification pathway support, and anti-aging effects on liver tissue.

liver support, detoxification, hepatic regeneration, longevity, anti-aging.

1 provider in the directory currently offers Ovagen.

Newsletter

The Peptide Research Digest

New providers, emerging stacks, and research developments — weekly.

No spam. Unsubscribe anytime. Privacy policy.